Home Cart Sign in  
Chemical Structure| 1435467-38-1 Chemical Structure| 1435467-38-1

Structure of PF-1355
CAS No.: 1435467-38-1

Chemical Structure| 1435467-38-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PF-1355 is a selective 2-thiouracil mechanism-based MPO inhibitor, used for treatment of vasculitic diseases.

Synonyms: PF-06281355

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PF-1355

CAS No. :1435467-38-1
Formula : C14H15N3O4S
M.W : 321.35
SMILES Code : O=C(N)CN(C(N1)=S)C(C2=CC(OC)=CC=C2OC)=CC1=O
Synonyms :
PF-06281355
MDL No. :MFCD29472589
InChI Key :LJBUZOGABRDGBR-UHFFFAOYSA-N
Pubchem ID :71568997

Safety of PF-1355

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P301+P312+P330

Related Pathways of PF-1355

ferroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
THP-1 macrophages 0.05–10 μg/mL 3 hours PF-1355 significantly attenuated clozapine-mediated increases in peroxidation activity in a dose-dependent manner Int J Mol Sci. 2023 Jan 8;24(2):1243

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague Dawley rats Clozapine-induced inflammation model Oral 100 mg/kg Single dose, lasting 24 hours PF-1355 pretreatment significantly attenuated clozapine-induced neutrophil mobilization and inflammatory mediator release Int J Mol Sci. 2023 Jan 8;24(2):1243
Mice MI and IRI models Oral 50 mg/kg Twice daily for 7 or 21 days Evaluate the therapeutic effects of PF-1355 on MI and IRI, including MPO inhibition, reduced inflammatory cell infiltration, improved cardiac function and remodeling JACC Basic Transl Sci. 2016 Dec 26;1(7):633-643

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.11mL

0.62mL

0.31mL

15.56mL

3.11mL

1.56mL

31.12mL

6.22mL

3.11mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories